{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","description":"OS was defined as the time from first dose to death due to any cause. Participant not known to have died by the end of study follow-up, observation of OS was censored on the date the participants were last known to be alive (i.e., date of last contact). Participants who lacked data beyond the day of first dose had their survival time censored on the date of first dose (i.e., OS duration of 1 day). Kaplan-Meier method was used for analysis.","reportingStatus":"NOT_POSTED","timeFrame":"From the first dose of study treatment until death or censoring date, whichever came first (approximately 61.7 months)","title":"Overall Survival (OS) by Central CD30 Assessment","type":"SECONDARY"}